Hara A, Watanabe T, Minaga K, Kamata K, Strober W, Kudo M
Front Immunol. 2025; 16:1554492.
PMID: 40040712
PMC: 11876061.
DOI: 10.3389/fimmu.2025.1554492.
Chen J, Cao R, Guo J, Liu Y, Hu H, Wan Q
J Int Med Res. 2024; 52(12):3000605241305433.
PMID: 39719070
PMC: 11683797.
DOI: 10.1177/03000605241305433.
Tusseau M, Khaldi-Plassart S, Cognard J, Viel S, Khoryati L, Benezech S
J Clin Immunol. 2024; 44(4):99.
PMID: 38619739
DOI: 10.1007/s10875-024-01696-8.
Kwon G, Wiedemann A, Steinheuer L, Stefanski A, Szelinski F, Racek T
NPJ Syst Biol Appl. 2023; 9(1):62.
PMID: 38102122
PMC: 10724199.
DOI: 10.1038/s41540-023-00319-z.
Hui-Yuen J, Jiang K, Malkiel S, Eberhard B, Walters H, Diamond B
Lupus Sci Med. 2023; 10(1).
PMID: 37202122
PMC: 10201247.
DOI: 10.1136/lupus-2023-000921.
B cell depletion therapies in autoimmune diseases: Monoclonal antibodies or chimeric antigen receptor-based therapy?.
Zhang Z, Xu Q, Huang L
Front Immunol. 2023; 14:1126421.
PMID: 36855629
PMC: 9968396.
DOI: 10.3389/fimmu.2023.1126421.
Unraveling the Link between Interferon-α and Systemic Lupus Erythematosus: From the Molecular Mechanisms to Target Therapies.
Infante B, Mercuri S, Dello Strologo A, Franzin R, Catalano V, Troise D
Int J Mol Sci. 2022; 23(24).
PMID: 36555640
PMC: 9783870.
DOI: 10.3390/ijms232415998.
Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibitor Evobrutinib in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Trial.
Wallace D, Dorner T, Pisetsky D, Sanchez-Guerrero J, Patel A, Parsons-Rich D
ACR Open Rheumatol. 2022; 5(1):38-48.
PMID: 36530019
PMC: 9837396.
DOI: 10.1002/acr2.11511.
Deciphering the Molecular Mechanism of Flares in Patients with Systemic Lupus Erythematosus through Single-Cell Transcriptome Analysis of the Peripheral Blood.
Papanikolaou S, Kosmara D, Stathopoulou C, Sidiropoulos P, Konstantopoulos D, Bertsias G
Mediterr J Rheumatol. 2022; 33(1):94-98.
PMID: 35611101
PMC: 9092108.
DOI: 10.31138/mjr.33.1.94.
PD-L1 and ICOSL discriminate human Secretory and Helper dendritic cells in cancer, allergy and autoimmunity.
Hoffmann C, Noel F, Grandclaudon M, Massenet-Regad L, Michea P, Sirven P
Nat Commun. 2022; 13(1):1983.
PMID: 35418195
PMC: 9008048.
DOI: 10.1038/s41467-022-29516-w.
SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies.
Graf M, von Stuckrad S, Uruha A, Klotsche J, Zorn-Pauly L, Unterwalder N
RMD Open. 2022; 8(1).
PMID: 35177553
PMC: 8860073.
DOI: 10.1136/rmdopen-2021-001934.
Targeting Toll-like Receptor (TLR) Pathways in Inflammatory Arthritis: Two Better Than One?.
Santos-Sierra S
Biomolecules. 2021; 11(9).
PMID: 34572504
PMC: 8464963.
DOI: 10.3390/biom11091291.
Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage.
Tsai C, Shen C, Liu C, Hsieh S, Liao H, Li K
Biomolecules. 2020; 10(12).
PMID: 33291347
PMC: 7762297.
DOI: 10.3390/biom10121641.
The regulation and pharmacological modulation of immune complex induced type III IFN production by plasmacytoid dendritic cells.
Hjorton K, Hagberg N, Pucholt P, Eloranta M, Ronnblom L
Arthritis Res Ther. 2020; 22(1):130.
PMID: 32503683
PMC: 7275601.
DOI: 10.1186/s13075-020-02186-z.
Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis.
Bertolo M, Baumgart S, Durek P, Peddinghaus A, Mei H, Rose T
Front Immunol. 2020; 11:256.
PMID: 32265898
PMC: 7105605.
DOI: 10.3389/fimmu.2020.00256.
[Biologicals and small molecules for systemic lupus erythematosus].
Aringer M, Leuchten N, Dorner T
Z Rheumatol. 2020; 79(3):232-240.
PMID: 32206866
DOI: 10.1007/s00393-020-00767-6.
Therapeutic Potential of ω-3 Polyunsaturated Fatty Acids in Human Autoimmune Diseases.
Li X, Bi X, Wang S, Zhang Z, Li F, Zhao A
Front Immunol. 2019; 10:2241.
PMID: 31611873
PMC: 6776881.
DOI: 10.3389/fimmu.2019.02241.
Molecular and Cellular Bases of Immunosenescence, Inflammation, and Cardiovascular Complications Mimicking "Inflammaging" in Patients with Systemic Lupus Erythematosus.
Tsai C, Shen C, Liao H, Li K, Lee H, Lu C
Int J Mol Sci. 2019; 20(16).
PMID: 31395799
PMC: 6721773.
DOI: 10.3390/ijms20163878.
MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies.
Tezcan G, Martynova E, Gilazieva Z, McIntyre A, Rizvanov A, Khaiboullina S
Front Pharmacol. 2019; 10:451.
PMID: 31118894
PMC: 6504709.
DOI: 10.3389/fphar.2019.00451.
Systemic Lupus Erythematosus: An Overview of the Disease Pathology and Its Management.
Ali A, Sayyed Z, Ameer M, Arif A, Kiran F, Iftikhar A
Cureus. 2018; 10(9):e3288.
PMID: 30443458
PMC: 6235637.
DOI: 10.7759/cureus.3288.